Cargando…
Emodin attenuates diabetic kidney disease by inhibiting ferroptosis via upregulating Nrf2 expression
Diabetic kidney disease (DKD) poses a threat to people’s health. The current treatments only provide partial relief of symptoms. Therefore, seeking a promising therapeutic medication for the prevention and control on DKD will benefit patients. Recently, a novel iron-dependent and non-apoptotic regul...
Autores principales: | Ji, Jing, Tao, Pengyu, Wang, Qian, Cui, Mengmeng, Cao, Mingfeng, Xu, Yuzhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457067/ https://www.ncbi.nlm.nih.gov/pubmed/37552124 http://dx.doi.org/10.18632/aging.204933 |
Ejemplares similares
-
The role and mechanism of gut microbiota-derived short-chain fatty in the prevention and treatment of diabetic kidney disease
por: Tao, Pengyu, et al.
Publicado: (2022) -
Emodin Attenuated the Kidney Damage of High-Fat-Diet Mice via the Upregulation of Glucagon-Like Peptide-1 Receptor
por: Liu, Jinlei, et al.
Publicado: (2021) -
Vitexin attenuates chronic kidney disease by inhibiting renal tubular epithelial cell ferroptosis via NRF2 activation
por: Song, Jiayu, et al.
Publicado: (2023) -
Mori fructus aqueous extracts attenuates liver injury by inhibiting ferroptosis via the Nrf2 pathway
por: Wei, Yuanyuan, et al.
Publicado: (2023) -
Dimethyl fumarate prevents ferroptosis to attenuate acute kidney injury by acting on NRF2
por: Yang, Yunwen, et al.
Publicado: (2021)